Tiziana Life Sciences Ltd
TLSANASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $56.50M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.76$2.10
- Volume (live)
- -
- Avg. volume (3M)
- 665.98K
Tiziana Life Sciences (TLSA) Stock Price & Financial Analysis
Tiziana Life Sciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.93 - $0.98 |
|---|---|
| 52-Week High | $2.10 |
| 52-Week Low | $0.76 |
| Open | $0.97 |
| Volume (last close) | 252.20K |
| Average Volume (3M) | 665.98K |
| 50-Day MA | $1.03 |
|---|---|
| 200-Day MA | $1.24 |
| 1-Year Change | −47.37% |
| Market Cap | 56.50M |
|---|---|
| Shares Outstanding | 59.47M |
| Price to Book (P/B) | 1086.54 |
| EV/EBITDA | -1.32 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Tiziana Life Sciences at a Glance
As of the Oct 23, 2026 close, Tiziana Life Sciences (TLSA) has a market capitalization of $56.50M.
As of its latest reported balance sheet, it holds $4.01M in cash and securities against $456.00K of debt, a net cash position of $3.55M.
Tiziana Life Sciences does not currently pay a dividend.
The share price is down 47.4% over the past year. At $0.95 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $0.76 to $2.10, below its 200-day moving average of $1.24.
Frequently Asked Questions About Tiziana Life Sciences
What is the current stock price for TLSA?
As of the Oct 23, 2026 close, TLSA stock trades at $0.95. The 52-week range is $0.76–$2.10, with a day range of $0.93–$0.98.
What is the P/E ratio for TLSA?
The P/E ratio (Price-to-Earnings) for TLSA is shown in the Key Statistics section. This valuation metric helps compare Tiziana Life Sciences Ltd to industry peers.
Does TLSA pay dividends?
Tiziana Life Sciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TLSA?
Analyst ratings and recommendations for TLSA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of TLSA?
As of the Oct 23, 2026 close, Tiziana Life Sciences's market capitalization is $56.5M, classifying it as a micro-cap company. Tiziana Life Sciences operates in the Healthcare sector within the Biotechnology industry.